KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$5.40 USD
+0.10 (1.89%)
Updated Oct 4, 2024 03:02 PM ET
After-Market: $5.40 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -2.43 |
EPS Last Quarter | -3.16 |
Last EPS Surprise | 28.34% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -11.76 |
Next Year | -6.67 |
EPS (TTM) | -13.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 3.89M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.43 | -2.53 | -11.76 | -6.67 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -2.15 | -2.15 | -10.94 | -6.67 |
High Estimate | -2.15 | -2.15 | -10.94 | -6.67 |
Low Estimate | -2.71 | -2.91 | -12.57 | -6.67 |
Year ago EPS | -3.41 | -3.18 | -17.35 | -11.76 |
Year over Year Growth Est. | 28.74% | 20.44% | 32.22% | 43.24% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.43 | -2.53 | -11.76 | -6.67 |
7 Days Ago | -2.43 | -2.53 | -11.76 | -6.67 |
30 Days Ago | -2.43 | -2.53 | -11.76 | -6.67 |
60 Days Ago | -4.53 | -2.55 | -14.49 | -7.57 |
90 Days Ago | -4.53 | -2.55 | -14.49 | -7.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.43 | -2.53 | -11.76 | -6.67 |
Zacks Consensus Estimate | -2.43 | -2.53 | -11.76 | -6.67 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.16 | -4.20 | -3.18 | -3.41 | NA |
Estimate | -4.41 | -2.89 | -3.62 | -2.15 | NA |
Difference | 1.25 | -1.31 | 0.44 | -1.26 | -0.22 |
Surprise | 28.34% | -45.33% | 12.15% | -58.60% | -15.86% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more